BTAI vs LOW · rev $388.0K vs P/E 18, rev $49.03B
BioXcel Therapeutics Inc (BTAI) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
BTAI currently screens at market cap $36.1M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the BTAI and LOW stock pages for the full models.
Not investment advice.